C. Jeffrey Dekker
Equibles does not estimate personal net worth.
Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ORKA alertsAbout C. Jeffrey Dekker
C. Jeffrey Dekker is recorded as CFO at Oruka Therapeutics, Inc. (ORKA). The newest filing on record that lists C. Jeffrey Dekker as CFO at Oruka Therapeutics, Inc. (ORKA) is dated April 18, 2025. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $756,604 for C. Jeffrey Dekker in fiscal 2024, including a base salary of $206,923. Disclosed compensation is on record for 2 fiscal years. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 18, 2025
-
Start not stated–2024-09-01
Company network
Leadership on record at Oruka Therapeutics, Inc.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- Laura Sandler COO
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
- Carl Dambkowski Board Member
- Chris Martin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Oruka Therapeutics, Inc. (ORKA) | Former Chief Financial Officer | $206,923 | $756,604 |
| 2023 | Oruka Therapeutics, Inc. (ORKA) | Former Chief Financial Officer | $270,000 | $323,072 |
Recent activity
No call appearances or filed executive changes recorded yet.